Advertisement

Irish Journal of Medical Science

, Volume 182, Issue 2, pp 185–190 | Cite as

A multicentre analysis of troponin use in clinical practice

  • J. D. Groarke
  • L. Browne
  • R. Margey
  • H. A. McCann
  • G. J. Blake
  • D. D. Sugrue
  • N. G. Mahon
Original Article

Abstract

Background

The role of troponin quantification in evaluation of patients with suspected acute coronary syndrome is established, but with cost implications. Emerging high-sensitivity troponin and novel multi-marker assays herald further resource implications.

Aims

The objective of this study was to quantify recent trends in troponin usage and costs in a cross-section of hospitals.

Methods

A cross-sectional survey seeking data on troponin usage and costs from six tertiary referral, public access teaching hospitals for consecutive years between 2003 and 2009 was carried out.

Results

A median annual increase in the volume of troponin assays requested was identified in all six hospitals, with an average median annual increase of 6.9 % across hospitals (interquartile range 3.4, 10.1 %). This annual increase was not accompanied by a corresponding increase in volume of patients presenting to the Emergency Department (ED) with chest pain. The majority (44–67 %) of troponin requests originated in the ED of hospitals. The median annual spend on troponins per hospital was €115,612 (interquartile range €80,452, €140,918). An analysis of results of assays performed in one centre found that the majority (91 %) of troponin assays performed were in the normal range.

Conclusions

An annual increase in troponin requests without a corresponding increase in patient activity raises the possibility of increasingly indiscriminate troponin testing. The cumulative direct and indirect costs of inappropriate testing are significant. Corrective strategies are necessary to improve patient selection and testing protocols, particularly in the advent of the high-sensitivity troponin assays and novel multi-marker strategies.

Keywords

Troponin T Cost analysis of troponin testing Duplicate troponin testing Inappropriate troponin testing 

Notes

Acknowledgments

The authors wish to acknowledge the help and data received from individuals working at the six hospitals that participated in this survey.

Conflict of interest

None.

References

  1. 1.
    Nawar EW, Niska RW, Xu J (2007) National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data 386:1–32PubMedGoogle Scholar
  2. 2.
    Pope JH, Aufderheide TP, Ruthazer R et al (2000) Missed diagnoses of acute cardiac ischaemia in the emergency department. N Engl J Med 342:1163–1170PubMedCrossRefGoogle Scholar
  3. 3.
    Speake D, Terry P (2001) Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. First ECG in chest pain. Emerg Med J 18:61–62PubMedCrossRefGoogle Scholar
  4. 4.
    Omland T (2010) New features of troponin testing in different clinical settings. J Intern Med 268:207–217PubMedCrossRefGoogle Scholar
  5. 5.
    Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959–969PubMedCrossRefGoogle Scholar
  6. 6.
    Thygesen K, Alpert JS, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525–2538PubMedCrossRefGoogle Scholar
  7. 7.
    Kavsak PA, MacRae AR, Newman AM et al (2007) Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta 380:213–216PubMedCrossRefGoogle Scholar
  8. 8.
    Lin JC, Apple FS, Murakami MM, Luepker RV (2004) Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Clin Chem 50:333–338PubMedCrossRefGoogle Scholar
  9. 9.
    Ilva TJ, Eskola MJ, Nikus KC, Voipio-Pulkki LM, Lund J, Pulkki K, Mustonen H, Niemelä KO, Karhunen PJ, Porela P (2010) The etiology and prognostic significance of cardiac troponin I elevation in unselected emergency department patients. J Emerg Med 38:1–5PubMedCrossRefGoogle Scholar
  10. 10.
    Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C (2007) Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 167:276–281PubMedCrossRefGoogle Scholar
  11. 11.
    Wong P, Murray S, Ramsewak A, Robinson A, van Heyningen C, Rodrigues E (2007) Raised cardiac troponin T levels in patients without acute coronary syndrome. Postgrad Med J 83:200–205PubMedCrossRefGoogle Scholar
  12. 12.
    Thygesen K, Mair J, Katus H et al (2010) Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 31:2197–2204PubMedCrossRefGoogle Scholar
  13. 13.
    Keller T, Tzikas S, Zeller T et al (2010) Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 55:2096–2106PubMedCrossRefGoogle Scholar
  14. 14.
    Keller T, Zeller T, Peetz J et al (2009) Sensitive troponin I assays in early diagnosis of acute myocardial infarction. N Engl J Med 361:868–877PubMedCrossRefGoogle Scholar
  15. 15.
    Reichlin T, Hochholzer W, Bassetti S et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–867PubMedCrossRefGoogle Scholar
  16. 16.
    Januzzi JL, Bamberg B, Lee H et al (2010) High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 121:1227–1234PubMedCrossRefGoogle Scholar
  17. 17.
    Fukuoka Y, Takeshima M, Ishii N et al (2010) An initial analysis: working hours and delay in seeking care during acute coronary events. Am J Emerg Med 28:734–740PubMedCrossRefGoogle Scholar
  18. 18.
    Dracup K, McKinley S, Riegel B et al (2009) A randomized clinical trial to reduce patient prehospital delay to treatment in acute coronary syndrome. Circ Cardiovasc Qual Outcomes 2:524–532PubMedCrossRefGoogle Scholar
  19. 19.
    Dekker MS, Mosterd A, van ‘t Hof AW, Hoes AW (2010) Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 96:1001–1010PubMedCrossRefGoogle Scholar
  20. 20.
    Reichlin T, Hochholzer W, Stelzig C et al (2009) Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 54:60–68PubMedCrossRefGoogle Scholar
  21. 21.
    Hunt SA, Abraham WT, Chin MH, American College of Cardiology, American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society et al (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112:e154–e235PubMedCrossRefGoogle Scholar
  22. 22.
    Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G et al (2008) Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442PubMedCrossRefGoogle Scholar
  23. 23.
    Rocchiccioli JP, McMurray JJ, Dominiczak AF (2010) Biomarkers in heart failure: a clinical review. Heart Fail Rev 15:251–273PubMedCrossRefGoogle Scholar
  24. 24.
    Maisel A, Mueller C, Nowak R et al (2010) Mid-region pro-hormone markers for the diagnosis and prognosis in acute dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062–2076PubMedCrossRefGoogle Scholar
  25. 25.
    Schull MJ, Vermeulen MJ, Stukel TA (2006) The risk of missed diagnosis of acute myocardial infarction associated with emergency department volume. Ann Emerg Med 48:647–655PubMedCrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2012

Authors and Affiliations

  • J. D. Groarke
    • 1
  • L. Browne
    • 1
  • R. Margey
    • 1
  • H. A. McCann
    • 1
  • G. J. Blake
    • 1
  • D. D. Sugrue
    • 1
  • N. G. Mahon
    • 1
  1. 1.Department of CardiologyMater Misericordiae University HospitalDublin 7Ireland

Personalised recommendations